{"id":3121,"date":"2019-09-06T13:06:07","date_gmt":"2019-09-06T13:06:07","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/2019-european-society-for-medical-oncology-conference\/"},"modified":"2019-09-06T13:08:26","modified_gmt":"2019-09-06T13:08:26","slug":"2019-european-society-for-medical-oncology-conference","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/2019-european-society-for-medical-oncology-conference\/","title":{"rendered":"2019\u00a0EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY conference"},"content":{"rendered":"<p>27 septembre &#8211; 1 octobre 2019<br \/>\nBarcelone, Espagne<\/p>\n<p>Â鶹Æƽâ°æ participera \u00e0 la conf\u00e9rence de l&#8217;ESMO afin de sensibiliser et de communiquer sur sa nouvelle et puissante mol\u00e9cule qui induit la mort cellulaire immunog\u00e8ne dans plusieurs types de tumeurs et inhibe la croissance tumorale chez les mod\u00e8les animaux. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>27 septembre &#8211; 1 octobre 2019<br \/>\nBarcelone, Espagne<\/p>\n<p>Â鶹Æƽâ°æ participera \u00e0 la conf\u00e9rence de l&#8217;ESMO afin de sensibiliser et de communiquer sur sa nouvelle et puissante mol\u00e9cule qui induit la mort cellulaire immunog\u00e8ne dans plusieurs types de tumeurs et inhibe la croissance tumorale chez les mod\u00e8les animaux. <\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/2019-european-society-for-medical-oncology-conference\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-3121","post","type-post","status-publish","format-standard","hentry","category-events-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/events-fr\/\" rel=\"category tag\">\u00c9v\u00e9nements<\/a>","rttpg_excerpt":"27 septembre &#8211; 1 octobre 2019 Barcelone, Espagne Â鶹Æƽâ°æ participera \u00e0 la conf\u00e9rence de l&#8217;ESMO afin de sensibiliser et de communiquer sur sa nouvelle et puissante mol\u00e9cule qui induit la mort cellulaire immunog\u00e8ne dans plusieurs types de tumeurs et inhibe la croissance tumorale chez les mod\u00e8les animaux. Lire la suite&nbsp;&raquo;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3121"}],"version-history":[{"count":3,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3121\/revisions"}],"predecessor-version":[{"id":3126,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3121\/revisions\/3126"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}